We characterized the <i>SLC19A3</i> gene variants using bioinformatics and analyzed DNA samples from controls, T2DM, and gout patients to explore associations with physical/laboratory parameters. This evidence concerns the gene SLC19A3 and type 2 diabetes mellitus.